Published: 24 April 2020
Author(s): Romy Schuttevaer, Anniek Brink, Jelmer Alsma, Willian van Dijk, Damian C. Melles, Jurriaan E.M. de Steenwinkel, Hester F. Lingsma, Annelies Verbon, Stephanie C.E. Schuit
Issue: August 2020
Section: Original article

Bacterial infections can result in considerable mortality and have a profound global burden [1–3]. Patients with a severe infection (e.g. sepsis) often present in an acute care setting, such as the emergency department (ED). To provide proper care in this setting, initiation of the antibiotic therapy that matches in vitro susceptibility of the causative bacteria (i.e. with appropriate coverage) is important [4]. However, the causative pathogen has yet to be identified by cultures and this process usually takes over 24 h.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.